Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1993-10-15
1996-01-16
Russel, Jeffrey E.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
530416, C07K 118, C07K 14755
Patent
active
054848903
ABSTRACT:
A method of recovering a purified and stabilized protein having antihemophilic factor activity (Factor VIII), from a biological sample containing Factor VIII, at least one destabilizing protease impurity, i.e. thrombin, and optionally one or more proprotease impurity, is provided. The biological sample is contacted with a protease removing and/or inhibiting agent, thereby inhibiting and/or removing the destabilizing protease impurity. The method provides increased yield and resolution of Factor VIII. Also provided are purified and stabilized Factor VIII non-lyophilized, liquid in compositions.
REFERENCES:
patent: 2833691 (1958-05-01), Klaas et al.
patent: 3803115 (1974-04-01), Fekete et al.
patent: 4264471 (1981-04-01), Briggs et al.
patent: 4361509 (1982-11-01), Zimmerman et al.
patent: 4388232 (1983-06-01), Eibl
patent: 4508709 (1985-04-01), Amphlett et al.
patent: 4522751 (1985-06-01), Linnay et al.
patent: 4743680 (1988-05-01), Mathews et al.
patent: 4847362 (1989-07-01), Mathews et al.
patent: 4952675 (1990-08-01), Mathews et al.
patent: 4965203 (1990-10-01), Silbering et al.
patent: 4970300 (1990-11-01), Fulton et al.
patent: 5043428 (1991-08-01), Heimburger et al.
patent: 5278289 (1994-01-01), Johnson et al.
Jane Gitschier et al., "Characterization of the Human Factor VIII Gene", Nature 312(22):326-330, Nov. 1984.
Wiliam I. Wood et al, "Expression of Active Human Factor VIII from Recombinant DNA Clones", Nature 312(22):330-337, Nov., 1984.
John J. Toole et al., "Molecular Cloning of a cDNA Encoding Human Antihaemophilic Factor", Nature 312(22):342-347, Nov., 1984.
V. J. Marder et al., "Standard Nomenclature for Factor VIII and Von Willebrand Factor: A Recommendation by the International Committee on Thrombosis and Haemostasis", Thrombosis and Haemostasis (Stuttgart) 54(4):871-872, 1985.
Jan Over et al., "Survival of 125 Iodine-Labeled Factor VIII in Normals and Patients with Classic Hemophilia", J. Clin. Invest., pp. 223-234.
Carol A. Edwards et al., "Tri(n-Butyl) Phosphate/Detergent Treatment of Licensed Therapeutic and Experimental Blood Derivatives", Vox Sang 52:53-59, 1987.
Edward G. D. Tuddenham, "The Properties of Factor VIII Coagulant Activity Prepared by Immunoadsorbent Chromatography", J. Lab. Clin. Med. 93(1), pp. 40-54, Jan., 1979.
John W. Fenton, "Human Thrombosis", J. Bio. Chem. 252(11):3587-3598, 1977.
H. J. Weiss, "A study of the Cation- and pH-Dependent Stability of Factors V and VIII in Plasma", Thrombosis et diathesis Haemorrhagica XIV(12):33-51, 1965.
E. G. Tuddenham et al. "Human Factor VIII Procoagulant Protein" (1982).
Mae B. Hultin et al., "The Activation and Inactivation of Human Factor VII by Thrombin: Effect of Inhibitors of Thrombin", Blood, 57(3):476-482, Mar. 1981.
R. Carr et al., "Abnormalities of Circulating Lymphocyte Subsets in Haemophiliacs in an AIDS-Free Population", The Lancet, pp. 1431-1434, Jun. 30, 1984.
J. Niemetz et al., "Activated Coagulation Factors: In-Vivo and in-Vitro Studies", Brit J. Haemat. 16:337-351, 1969.
G. A. Rock et al., "Stability of VIII:C in Plasma: The Dependence on Protease Activity and Calcium", Thrombosis Research 29:521-535, 1983.
P. R. Foster et al., "Improving Yield in the Manufacture of VIII Concentrates", Scand J. Haematol. Supp. 40, 33:103-110, 1984.
Carol A. Fulcher et al., "Thrombin Proteolysis of Purified Factor VIII Procoagulant Protein: Correlation of Activation with Generation of a Specific Polypeptide", Blood 61(4):807-811, Apr. 1983.
Gordon A. Vehar et al., "Structure of human factor VIII", Nature 312(22):337-342, Nov. 1984.
Frances Rotblat et al., "Purification of Human Factor VIII:C and Its Characterization by Western Blotting Using Monoclonal Antibodies", Biochemistry 24:4294-4300, 1985.
"Factor VIII Degradation Products in Heated Concentrates", The Lancet, pp. 1448-1449, Jun. 21, 1986.
Carol A. Fulcher et al., "Characterization of the Human Factor VIII Procoagulant Protein with a Heterologous Precipitating Antibody", P.N.A.S., USA 79:1648-1652, Mar., 1982.
Alan J. Johnson et al., "Studies on the Purification and Characterization of VIII:C" (1982).
J. J. Morgenthaler, "Chromatography of Antihemophilic Factor on Diaminoalkane- and Aminoalkane-Derivatized Sepharose", Thromb Haemostas (Stuttgart) 47(2):124-127, 1982.
Roger L. Lundblad et al., "The Effect of Dextrose on Chromatography of Antihemophilic Factor (Factor VIII)", Thrombosis Research 1:197-200, 1972.
Harvey J. Weiss, "Von Willebrand Factor: Dissociation form Antihemophilic Factor Procoagulant Activity", Science, 18:1149-1151, Dec., 1973.
Leon W. Hoyer, Plasma Coagulation Factors, "Factor VIII", Chptr. 4, 1987.
Carol A. Fulcher et al., "Human Factor VIII Procoagulant Protein", J. Clin Invest. 76:117-124, Jul. 1985.
Dan Eaton et al., "Proteolytic Processing of Human Factor VIII. Correlation of Specific Cleavages by Thrombin, Factor Xa, and Activated Protein C with Activation and Inactivation of Factor VIII Coagulant Activity", American Chemical Society, pp. 505.512, 1986.
C. Orthner "Characterization of Proteases in AHF Concentrates", Mar. 11, 1985, J. Lab Clin Med., vol. 104, No. 5, 1984, pp.816-828.
Fulton Anne J.
Johnson Alan J.
LandOfFree
Antihemophilic factor stabilization does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antihemophilic factor stabilization, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antihemophilic factor stabilization will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-310363